Newsletter March 2021 | EPO Berlin Buch GmbH

Company
Tumor models
Services
News
Contact

Newsletter March 2021

Tumor Model Insights 03/2021: Partially temozolomide resistant, IDH-wildtype glioblastoma PDX model (Glio10618)

© EPO Berlin-Buch GmbH 2025

Experimental Pharmacology
& Oncology Berlin-Buch GmbH

Robert-Rössle-Str. 10
13125 Berlin-Buch, Germany

Tel.: +49 (0)30 9489 4440
Fax: +49 (0)30 9489 4441

Stay updated with our Newsletter

Legal information
Terms and conditions
Privacy policy